Dendritic Cell Control of Intestinal T Cell Responses
Dendritic Cell Control of Intestinal T Cell Responses
批准号:
8690042
负责人:
Adam Lacy-Hulbert
金额:
$37.19万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-05 至 2016-06-30
关键词:
Antigen-Presenting CellsAntigensAutoimmune DiseasesAutoimmunityBiochemicalCD4 Positive T LymphocytesCell CommunicationCell Differentiation processCellsCellular biologyChronicColitisComplexDataDendritic CellsDendritic cell activationDevelopmentDietDiseaseEquilibriumGenerationsGoalsHelper-Inducer T-LymphocyteHumanIL17 geneImmune ToleranceImmune responseImmune systemImmunityInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineIntegrinsInterferonsInterleukin-1Interleukin-17IntestinesKnockout MiceLicensingLinkMaintenanceMediatingModelingMolecularMusMyeloid CellsPathologyPeptide HydrolasesPhenotypePlayPopulationPreventionPrimary Cell CulturesProcessProductionPropertyPublishingReactionRegulationRegulatory T-LymphocyteRoleSignal TransductionStimulusSurfaceT cell responseT-LymphocyteTestingTh1 CellsTranslatingWorkbasecommensal microbescytokinein vivoinnovationinterleukin-23intestinal epitheliummicroorganismmucosal sitepathogenpreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mucosal surfaces such as the intestinal epithelium provide a complex challenge to the immune system, as they must maintain effective immunity against potential pathogen attack while also tolerating commensal microorganisms and dietary antigens. The balance between tolerance and immunity is mediated in large part by the specialized T cell populations, regulatory T cells (Tregs) and Th17 cells. Disruption of the balance between these subsets has been heavily implicated in causing colitis through studies in both mice and humans. Furthermore, Th17 cells are emerging as contributors to many other inflammatory and autoimmune disorders. Understanding how Th17 responses are initiated and regulated is therefore critical to our understanding of both intestinal immunity and chronic inflammatory disease. Our long term goal is to understand how Dendritic Cells (DCs) and other antigen presenting cells initiate and maintain the correct balance of T-helper cell subsets. The objective in this application is to establish how DCs regulate T cell responses to TGF-¿ and control Th17 cell differentiation. The rationale for this work is that understanding this process has the potential to translate into new therapies for Th17-mediated diseases. Our central hypothesis is that DC expression of ¿v¿8 and subsequent activation of TGF-¿ controls induction and maintenance of Th17 responses. Based on published work and preliminary data, this hypothesis will be tested in three specific aims: (1) Determine how ¿v integrins expressed by DCs regulate Th17 cell differentiation, particularly the generation of IL17/ IFN-?-expressing cells
associated with autoimmunity. Conditional knockout mice will be used to study the role for ¿v integrins in vivo, and results will be extended to humans though primary cell culture. (2) Understand how ¿8 expression is regulated in DCs during homeostatic regulation and following infection. (3) Determine the mechanisms by which ¿v¿8 function is regulated on DCs using cell biology and biochemical approaches. This approach is innovative as it focuses on the role of DCs in 'licensing' T cell responses to TGF-¿. The proposed work is significant because it will provide a much needed understanding of how DCs promote the initiation of Th17 cells in the intestine and regulate their subsequent differentiation in response to environmental and infectious challenges.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LITAF regulation of cell death and inflammatory responses
-
批准号:10886166
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2023
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Immune Signatures and Clinical Outcomes in Acute Pancreatitis
-
批准号:10568011
-
项目类别:
-
资助金额:$75.76万
-
财政年份:2023
-
负责人:Adam Lacy-Hulbert
-
依托单位:
alpha v integrin regulation of B cell tolerance
-
批准号:10294130
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2020
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
-
批准号:8956296
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2015
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
-
批准号:9089858
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2015
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
-
批准号:8883359
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2014
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
-
批准号:8490300
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Dendritic Cell Control of Intestinal T Cell Responses
-
批准号:8868105
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Dendritic Cell Control of Intestinal T Cell Responses
-
批准号:8372489
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Transposon Mutagenesis for Host-Target and Drug Discovery in Infectious Disease
-
批准号:8391403
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Dendritic Cell Control of Intestinal T Cell Responses
-
批准号:8843114
-
项目类别:
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Dendritic Cell Control of Intestinal T Cell Responses
-
批准号:8503610
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2012
-
负责人:Adam Lacy-Hulbert
-
依托单位:
2011 Apoptotic Cell Recognition and Clearance Gordon Research Conference and Gord
-
批准号:8193665
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2011
-
负责人:Adam Lacy-Hulbert
-
依托单位:
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
-
批准号:7932815
-
项目类别:
-
资助金额:$77.27万
-
财政年份:2006
-
负责人:Adam Lacy-Hulbert
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: